TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Caregivers' feelings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HbA1c (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: physiological strain (composite)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Product-related adverse and serious adverse experiences
Endpoint domain: Adverse events/effects
Primary endpoint: HIV and rAdenovirus type 5 (rAd5) T-cell and antibody immune responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Efficacy to reach the clot site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Global Rating of Change (GRC)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Respiratory monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Skin conductance monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in potential SEBs relevant to endometrial carcinogenesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: 4 Cycle Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants died due to any cause
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of left ventricular mural thrombosis or silent brain infarct
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Bowel preparation pass rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of subjects achieving ACR20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of PAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Immediate post-operative opioid requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Acute heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Behavioral probability of taking a shortcut
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fMRI activation level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neural memory representation reactivation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Valproate dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of Oral Nutrition Supplement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cmax: Maximum Observed Plasma Concentration for TAK-536
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax: Time to Reach the Maximum Plasma Concentration for TAK-536
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC∞: Area Under the Plasma Concentration-time Curve for TAK-536
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Subjects With One-year Success
Endpoint domain: Mortality/survival
Primary endpoint: Respiratory Muscle Endurance Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Inspiratory Flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Inspiratory Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Passive Leg Rising
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of proinflammatory/anti inflammatory cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Complications including anastomotic leakage
Endpoint domain: Adverse events/effects
Primary endpoint: Problems with ring evacuation
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of suicide reattempt (SR) rate
Endpoint domain: Mortality/survival
Primary endpoint: Treatment completion/adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of successful blood draws
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Best correct visual acuity (BCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean ADL Difficulty Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Capacity of muscle fibers to consume oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Bacterial Culture Growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Posaconazole Exposure (Total Plasma Concentration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posaconazole Exposure (Unbound Concentrations)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global assessment of IBS symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Length of vaso-occlusive crisis (VOC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of central retinal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anterior chamber cell score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 11-gene set / Sepsis MetaScore
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Chronic GVHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Progression-free survival rate 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Performance on working memory measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vancouver Scar scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: intercanthal distance ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Moderate and Vigorous Physical Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stool Microbiome Composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety by measurement of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of LDO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of carboplatin and docetaxel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Days With Weight-monitoring on Sensor Logs at 6 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Days With Weight-monitoring on Sensor Logs at 12 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: clinical benefits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Relative risk reduction for mortality
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Participants Reporting Treatment-Emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Alzheimer's Disease Assessment Scale-Cognitive Subscale 11 (ADAS-Cog 11)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Alzheimer's Disease Cooperative Study Group-Activities of Daily Living (ADCS-ADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Follow-up outcomes in breast cancer patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Improvement in IGA by Two or More Points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of diabetic peripheral neuropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Presence of diabetic peripheral neuropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Liver steatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Short Physical Performance Battery, total time (SPPB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed up and Go tests, total time (TUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static Balance tests, total time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms of GERD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of PF-ILD and SSc-ILD patients
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of PF-ILD and SSc-ILD patients
Endpoint domain: Mortality/survival
Primary endpoint: Healthcare resource use of PF-ILD and SSc-ILD patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in mean pain intensity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective leak data (L/min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance between imaging sequences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventilator-free days at 28 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of neurofeedback sessions completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Subjects With at Least One Treatment-Emergent Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of procedural time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of acute adverse events using VIVO system for non-invasive mapping
Endpoint domain: Adverse events/effects
Primary endpoint: Absence of acute adverse events using VIVO system for mapping and during the whole ablation procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Peak Plasma Concentration (Cmax) of 2% Diltiazem
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: blood single cell transcriptome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of participants alive at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Diagnostic accuracy of rEndosc for esophageal varices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Diagnostic accuracy of the hypoglycaemia warning system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platelet activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood Oxygen Level Dependent (BOLD) brain signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Performance on Cognitive Testing
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Time to clinical recovery after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of aggravation
Endpoint domain: Adverse events/effects
Primary endpoint: Sleep initiation
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Depth of sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Most prominent sleep stage on EEG
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Uric acid level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: DASH Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pruritus VAS Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in serum AFB1-lysine adducts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in urinary AFM1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in naming performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Vital Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of adverse events (AEs) and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients experiencing any dose limiting toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Reintervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Post operative Major cardiovascular adverse events (MACE)
Endpoint domain: Adverse events/effects
Primary endpoint: Medication Reconciliation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Acute kidney injury requiring renal replacement therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of subjects with moderate or less MR (≤2+)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Disengagement rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in chemical mediators in nasal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rates of Infection of Clean-contaminated Surgical Wounds
Endpoint domain: Adverse events/effects
Primary endpoint: Massachusetts General Hospital Hair Pulling Scale (MGHHPS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: NIMH Trichotillomania Severity Scale (NIMH-TSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NIMH Trichotillomania Impairment Scale (NIMH-TIS)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in EPAO-SR Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Test of Upper Limb Apraxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unbound Ceftolozane Exposure in the Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unbound Tazobactam Exposure in the Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unbound Ceftolozane Exposure in the CSF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unbound Tazobactam Exposure in the CSF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frailty
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Area Under the Curve of Virus Load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Ocular Comfort Rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Distance Visual Acuity (VA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced intestinal permeability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: proportion of patients with new vertebral fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Energy expenditure - MET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy expenditure - kcal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Modified Neuropathy Impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Seroprevalence of anti-HEV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cumulative Complete Remission (CR) / CR with incomplete blood count (CRi) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving sPGA Score of Clear or Almost Clear
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Variability of clinical expression of neurofibromatosis 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CME testing results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic Evaluation for Bone Density using Cone Beam CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients Achieving Seated Systolic Blood Pressure Goal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of pain medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cardiopulmonary Exercise Test Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Biochemical Markers of Bone Turnover
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of grade 2 or higher haemorrhagic episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Uptake of cancer genetic counseling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serum concentration of inflammatory biomarker (hs-CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Block Onset time difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in percentage of Foxp3+Treg cells among total lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants With P.Falciparum Blood Stage Infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Participants Requiring Treatment With Additional Anti-malarial Medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants With Local and Systemic Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Patient Feedback Regarding Videos
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient Attention During Videos
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Assess implantation of video series
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to TB treatment initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: cell colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of the extracellular matrix
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection rate of solid focal lesion in liver
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative image quality analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with a Complete Response (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Barrett oesophagus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Richards-Campbell Sleep Questionnaire (RCSQ)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Mini Nutritional Assessment- Short Form (MNA-SF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Presence of Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Administration of Rescue Pain Medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to first Administration of Acetaminophen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality after total hip replacement
Endpoint domain: Mortality/survival
Primary endpoint: Morbidity after total hip replacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Number of Detectable Plaque Bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Presence of ADAb
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 6 Minute Push Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30 Second Sprint Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sputum OPG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Very Good Partial Response (VGPR) Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median Time for Neutrophil and Platelet Engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of dose limiting adverse events (every 2 week cycle)
Endpoint domain: Adverse events/effects
Primary endpoint: Assessment of overall response rate using standard imaging and RECIST 1.1 criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of dose limiting adverse events (every 3 week cycle)
Endpoint domain: Adverse events/effects
Primary endpoint: Viral load count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in sleep efficiency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Reader Confidence in s-DCT Images Compared to Conventional CT
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Change in A1C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes